Tellgen Corporation (300642)
SZSE
Real-time Data
01:30 AM
Day's Range
16.2052 wk Range
11.04Overview - 300642 - Tellgen Corporation
Key Statistics
Valuation
Enterprise Value
2.65B
P/E (Trailing)
‪167.00‬
P/E (Forward)
‪20.52‬
PEG Ratio
‪20.52‬
Price / Sales (TTM)
‪7.13‬
Price / Book
‪1.95‬
EV / EBITDA
‪36.13‬
Profitability
Gross Margin
‪64.87%‬
Profit Margin
‪3.13%‬
Operating Margin
‪14.32%‬
Return on Assets
‪0.60%‬
Return on Equity
‪0.64%‬
Ownership
Shares Outstanding
162.54M
Float
114.94M
Held by Insiders
‪33.73%‬
Held by Institutions
‪7.98%‬
Price stats
50-Day Avg
‪12.74‬
200-Day Avg
‪16.40‬
Dividends
Payout Ratio
‪152.59%‬
Frequency
Annual
Market Cap - 300642 - Tellgen Corporation
Peers - 300642 - Tellgen Corporation
Peer Comparison
Compared with companies in Medical Devices listed on SZSE.
Profile Summary - 300642 - Tellgen Corporation
About
Tellgen Corporation is a leading player in the biotechnology industry, specializing in the development and production of in vitro diagnostic products. Its primary function is to provide reliable diagnostic solutions that aid in the detection, diagnosis, and management of diseases and health conditions. Tellgen's…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
